Orphan Drugs Market: Redefining Hope Through Breakthrough Therapies for Rare Diseases
In the world of healthcare, most medical conditions receive attention proportional to the number of people affected. But what happens when a disease impacts only a small number of individuals—sometimes just a few hundred globally? For years, these rare or “orphan” diseases remained on the sidelines, under-researched and under-treated. Today, the landscape is changing dramatically. The orphan drugs market is becoming one of the most innovative and fastest-growing sectors in global healthcare, reshaping expectations for millions of patients and families.
